More than 80 million people around the world are estimated to be infected with Hepatitis C. Each year, 700,000 people die from complications of the disease. In many countries, people who inject drugs are the population most affected.

If the World Health Organisation (WHO) goal of eradication of Hepatitis C by 2030 is to be reached, figuring out how to treat people who inject drugs, delivered in conjunction with harm reduction programs, will be key.

INHSU 2016 brings together research from around the world to address this issue, forming evidence-based recommendations for the optimal management of Hepatitis C in substance users.

What:                            5th International Symposium on Hepatitis Care in Substance Users

Where:                          Radisson Blu Scandinavia Hotel, Oslo, Norway

When:                           September 7-9, 2016

• View the conference program
• Visit the list of invited speakers and their research
• Follow us on Twitter
• Find out more about INHSU

Media are invited to attend the event for free or contact Petrana@arkcommunications.com.au for further information about upcoming media releases.